Research Article

High Burden of On-Going HSV-1 and -2 Infections in Human Immunodeficiency Virus-Infected Individuals in a Secondary Healthcare Facility in Imo State, Nigeria

Udeze A.O1*, Adeoti O.T2, Ogunrinola O.T2, Sule W.F3
1 Virology Unit, Department of Microbiology, University of llorin, P.M.B 1515 Ilorin-Nigeria
2 Virology Unit, Department of Microbiology, University of Ilorin, P.M.B 1515 Ilorin Nigeria
3 Department of Biological Sciences, College of Science, Engineering and Technology, Osun State University, PMB 4494, Osogbo, Osun State, Nigeria
* Corresponding author: udeze.ao@unilorin.edu.ng
Published: Jun, 2019
DOI: 10.67614/njm.2019.831h3la5
Pages: 4387 - 4396

Abstract

Because of shared route of transmission of human immunodeficiency virus type 1 (HIV-1), herpes  simplex virus type 1(HSV-I) and type 2 (HSV-2), HIV-1-infected persons are also susceptible to infection by  HSV-1 and HSV-2. This study aimed at determining the prevalence of HSV-1 and HSV-2 IgM antibodies  among HIV-infected individuals accessing healthcare at General Hospital, Awo-Omamma Imo state, Nigeria.  This is a hospital-based cross-sectional study. Blood samples were collected from 182 (38 males and 144  females: age range 3-72 years; mean age 36.5 years) HIV-infected participants on ART after collecting pertinent  socio-demographic data using questionnaires. Serum from each sample was tested for the presence of IgM  antibodies against HSV-1 and -2 using ELISA. Data were analysed using Chi-squared test and binary logistic  regression analysis with SPSS 15.0 for Windows. Of the 182 samples tested, 166 (91.2%) and 156 (85.7%) were  respectively positive for HSV-1 and HSV-2 while 148 (81.3%) were positive for both HSV-1 and HSV-2 IgM  antibodies. These respectively represented dual HIV/HSV-1, HIV/HSV-2 and triple HIV/HSV-1/HSV-2  infection rates. Variables analysed as risk factors include patients’ gender, age group, marital status, educational  status and CD4+ cell count. Age was predictive of HIV/HSV-1 dual infection while gender and age were both  predictive of HIV/HSV-2 dual infection rates among the participants. This study reports high seroprevalence of  both HSV-1 and HSV-2 IgM antibodies among this cohort. Mass education targeted especially at the most  vulnerable groups on the dangers and ways of preventing these infections is recommended.

Keywords

HIV-patients HSV-1 HSV-2 IgM antibodies risk factors

References

  1. Allen, P.S., Das, S. (2004). Prevalence of HSV-1/HSV-2 antibodies in HIV seropositive patients in Coventry, United Kingdom. Sexually Transmitted Infections 80(1) e77. DOI 10.1136/sti.2002.003343
  2. Andreoletti, L, Piednoir, E, Legoff, J, Brodard, V, Beguinot, I, Strady, C, Kouger, C, Pikety, C, Si-Mohamed, A, Kazatchkine, M.D, Malkin, J-E., Belec, L. (2005). High Seroprevalence of Herpes Simplex Virus Type 2 Infection in French Human Immunodeficiency Virus Type 1-Infected Outpatients. Journal of Clinical Microbiology 43(6):4215-4217.
  3. Anuradha, K., Singh, H.M., Gopal, K.V.T., Rao, G.R.R, Ramani, T.V., Padmaja, J. (2008). Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals. Indian Journal of Dermatology, Venereology and Leprology 74(3):230-233.
  4. Arama, V., Cercel, A.S., Vladareanu, R., Mihai, C., Mihailescu, R., Rankin, J., Gioschin, N., Filipescu, A., Rafila, A., Arama, S., Hriscea, A., Malkin, J.E., Pimenta, J.M., Smith, J.S. (2010). Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men. International Journal of Infectious Diseases 14 (Suppl 3):e25-31.
  5. Augenbraun, M., Feldman, J., Chirgwin, K., Zenilman, J., Clarke, L., DeHovitz, J., Landesman, S., Minkoff, H. (1995). Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Annals of Internal Medicine 123: 845-847.
  6. Barnabas, R.V. and Celum, C. (2012). Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions. Current HIV Research, 10:228- 237.
  7. Burger, H. and Weiser, B. (2001). Biology of HIV-1 in women and men. Clinical Obstetrics and Gynecology 44: 137–143.
  8. Buxbaum, S., Geerts, M., Gross, G., Schöfer, H., Rabenau, H.F., Doerr, H.W. (2003). Epidemiology of herpes 143-4simplex virus types 1 and 2 in Germany: What has changed? Medical Microbiology and Immunology 192:177-181
  9. Celum, C.L., Robinson, N.J., Cohen, M.S. (2005). Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. Journal of Infectious Diseases 191 Suppl 1:S107-S114.
  10. Corey, L., Wald, A, Celum, C.L, Quinn, T.C. (2004). The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of Acquired Immune Deficiency Syndrome 35:435-45.
  11. Cowan, F.M., Copas, A., Johnson, A.M., Ashley, R., Corey, L., Mindel, A. (2002). Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sexually Transmitted Infections 78:346–348.
  12. Duru, C.B., Emele, F.E., Nnebue, C.C., Adinma, E.D., Ifeadike, C.O., Amilo, G.I., Otubuyo, A.O., Otubuyo, B.O. (2014). The Seroprevalence and Co-Existence of Chlamydia Trachomatis and Herpes Simplex Virus Antibodies among Students in a Tertiary Institution. International Invention Journal of Medicine and Medical Sciences, 1(8):122-130.
  13. Erlich, K., Safrin, S., Mills, J. (1995). Herpes simplex virus. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base: A Textbook on HIV Disease, 2nd ed. New York: Little Brown, 1-6, 12-19.
  14. Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A.,Hayes, R.J. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73–83.
  15. Ghebremichael, M., Larsen, U. and Paintsil, E. (2009). Association of Age at First Sex with HIV-1, HSV-2 and other Sexual Transmitted Infections among Women in Northern Tanzania. Sexually Transmitted Diseases 36(9): 570-576.
  16. Jacob, S, Gopal, T., Kanagasabai, A., Durairaj, A., Sushi, K., Arumugam, G. (2015). Herpes Simplex Virus 2 infection in HIV-seropositive individuals in Tamil Nadu, India. International Journal of Medical Science and Public Health 4(3):404-407.
  17. Johnston, C., Koelle, D.M., Wald, A. (2011). HSV-2: in pursuit of a vaccine. The Journal of Clinical Investigation 121(12):4600-4609.
  18. Kamali, A., Nunn, A.J., Mulder, D.W., Van Dyck, E, Dobbins, J.G, Whitworth, J.A. (1999). Prevalence and incidence of genital ulcer infections in a rural Ugandan population. Sexually Transmitted Infections 75: 98-102
  19. Kapiga, S.H., Sam, N.E., Bang, H., Ni, Q., Ao, T.T.H., Kiwelu, I., Chiduo, S., Ndibe, U., Seage III, G., Coplan, P., Shao, J., Rosenberg, Z.F., and Essex, M. (2007). The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. Journal of Infectious Diseases 195:1260–1269.
  20. Kaul, R., Kimani, J., Nagelkerke, N.J., Fonck, K., Ngugi, E.N., Keli, F., MacDonald, K.S., Maclean, I.W., Bwayo, J.J., Temmerman, M., Ronald, A.R., Moses, S. (2004). Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infection reinfections in Kenyan sex workers: a randomized controlled trial. Journal of American Medical Association 291:2555-2562
  21. Kim, R.N., Meier, A., Huang, M.L., Kuntz, S., Selke, S, Celum, C, Corey, L., Wald, A. (2006). Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men. Journal of Infectious Diseases 194:420-427.
  22. Lama, J.R., Lucchetti, A., Suarez, L., Laguna-Torres, V.A., Guanira, J.V., Pun, M., Montano, S.M., Celum, C., Carr, J.K., Sanchez, J., Bautista, C.T., Sanchez, J.L. (2006). Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. Journal of Infectious Diseases 194:1459–1466.
  23. Lazcano-Ponce, E., Smith, J.S., Munoz, N., Conde-Glez, C.J., Juarez, F.L., Cruz, A., Hernandez, P. (2001). High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico: a population-based study. Sexually Transmitted Diseases 28(5): 270-276.
  24. Mawak, J.D., Dashe, N., Atseye, A., Agabi, Y., Zakeri, H. (2012). Seroprevalence and co-infection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria. Shiraz E-Medical Journal 13(1):33-39.
  25. McFarland, W., Gwanzura, L., Bassett, M.T., Machekano, R., Latif, A.S., Ley, C., Katzenstein, D. (1999). Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. Journal of Infectious Diseases 180:1459-1465
  26. McMahon, M.A., Parsons, T.L., Siliciano, R.F. (2007). Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses. Journal of Virology 85(9):4818-4822.
  27. Mertz, G.J., Benedetti, J., Ashley, R., Selke, S.A., Corey, L. (1992). Risk factors for the sexual transmission of genital herpes. Annals of Internal Medicine 116(3):197-202
  28. Moulignier, A., Baudrimont, M., Martin-Negrier, M.L., Mikol, J., Lapresle, C., Dupont, B. (1996). Fatal brain stem encephalitis due to herpes simplex virus type 1 in AIDS. Journal of Neurology 243:491-493.
  29. Msuya, S.E., Mbizvo, E., Hussain, A., Sam, N.E., Jeansson, S., StrayPedersen, B. (2003). Seroprevalence and correlates of herpes simplex virus type 2 among urban Tanzanian women. Sexually Transmitted Diseases 30(7): 588-592.
  30. Muiru, A.N., Guthrie, B.L., Bosire, R., Merkel, M., Liu, A.Y., Choi, R.Y., Lohman-Payne, B., Gatuguta, A., Mackelprang, R.D., Kiarie, J.N., and Farquhar, C. (2013). Incident HSV-2 infections are common among HIV-1-discordant couples. Journal of Infectious Diseases 208:1093-1101.
  31. Niang, L., Winn, T., Rusil, B.N. (2006). Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences 1: 9-14.
  32. Njuguna, H., Mutugi, M., Onchiri, F., Cohen, C. and Bukusi, E. (2012). Herpes simplex virus type 2, HIV, and Antiretroviral therapy knowledge and beliefs in the general population of Kisumu, Kenya. Journal of AIDS and HIV Research 4(1): 17-25.
  33. Santos, F.C., de Oliveira, S.A., Setúbal, S., Camacho, L.A.B., Faillace, T., Leite, J.P.G., Velarde, L.G.C. (2006). Seroepidemiological study of herpes simplex virus type 2 in patients with the acquired immunodeficiency syndrome in the City of Niterói, Rio de Janeiro, Brazil. The Memórias do Instituto Oswaldo Cruz, Rio de Janeiro 101(3):315-319.
  34. Schacker, T, Zeh, J., Hu, H., Shaughnessy, M. and Corey, L. (2002). "Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression," Journal of Infectious Diseases 186(12):1718–1725.
  35. Schacker, T., Zeh, J., Hu, H.L., Hill, E., Corey, L. (1998). Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. Journal of Infectious Diseases 178:1616-1622.
  36. Smith, J.S., Robinson, N.J. (2002). Age-specific prevalence of infection with herpes simplex virus types 1 and 2: A global review. Journal of Infectious Diseases 186(Suppl 1):S3-S28.
  37. Suligoi, D., Dorrucci, M., Volpi, A., Andreoni, M., Zerboni, R., and Rezza, G. (2002). Age-specific and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sexually Transmitted Diseases 29: 665-667.
  38. Tada, D.G. and Khandelwal, N. (2012). Serum HSV-1 and 2 IgM in Sexually Transmitted Diseases - More for Screening Loss for Diagnosis: An Evaluation of Clinical Manifestation. Journal of Global Infectious Diseases 4(3): S1-S4.
  39. Tan, D.H.S, Kaul, R., Walmsley, S. (2009). Left out but not forgotten: Should clinical attention be paid to coinfection with herpes simplex virus type 1 and HIV? Canadian Journal of Infectious Diseases and Medical Microbiology 20(1): e1-e7.
  40. Tan, D.H.S, Rabuad, J.M, Kaul, R., Walmsley, S.L. (2014). Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study. British Medical Journal Open 4:e004010.
  41. Tideman, R.L., Taylor, J., Marks, C., Seifert, C., Berry, G., Trudinger, B., Cunningham, A., Mindel, A. (2001). Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sexually Transmitted Infections 77:413-415
  42. Uneke, C.J, Ogbu, P.U.I, Anyanwu, G.I, Njoku, M.O., Idoko, J.H. (2005). Prevalence of hepatitis B surface antigen and herpes simplex virus type 2 among blood donors and HIV-infected patients in Jos, Nigeria. Memórias do Instituto Oswaldo Cruz Rio de Janeiro 100(1): 13-16.
  43. van Benthem, B.H., Spaargaren, J., van den Hoek, J.A., Merks, J., Coutinho, R.A., Prins, M. (2001). Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sexually Transmitted Infections 77:120-4
  44. Wald, A. (2004). Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 11(Suppl. 3):130A-137A.
  45. Wald, A., Link, K. (2002). Risk of human immunodeficiency virus infection in herpes simplex virus type 2–seropositive persons: a meta-analysis. Journal of Infectious Diseases 185: 45-52.
  46. Ward, H., Ronn, M. (2010). Contribution of sexually transmitted infections to the sexual transmission of HIV. Current Opinion in HIV and AIDS 5: 305-310.
  47. WHO. (2004). Guidelines for HIV surveillance among tuberculosis patients. WHO/HTM/TB/2004.339; WHO/HIV/2004.06, 2nd Edn. Geneva, Switzerland.
How to Cite

A.O, U., O.T, A., O.T, O., & W.F, S. (2019). High Burden of On-Going HSV-1 and -2 Infections in Human Immunodeficiency Virus-Infected Individuals in a Secondary Healthcare Facility in Imo State, Nigeria. Nigerian Journal of Microbiology, 33(1), 4387 - 4396. https://doi.org/10.67614/njm.2019.831h3la5

U. A.O, A. O.T, O. O.T, and S. W.F, "High Burden of On-Going HSV-1 and -2 Infections in Human Immunodeficiency Virus-Infected Individuals in a Secondary Healthcare Facility in Imo State, Nigeria," Nigerian Journal of Microbiology, vol. 33, no. 1, pp. 4387 - 4396, June 2019. doi: 10.67614/njm.2019.831h3la5

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles